Search research articles
Contact Us
Filters
Showing results (151-160 of 269) with videos related to
Page
of 27
Sort By:
Gut
|
February 20, 2016
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
October 3, 2015
Fc Receptor-mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of Inflammatory Bowel Disease
Bradford L McRae, Alon D Levin, Manon E Wildenberg, et al.
Journal of Crohn'S & Colitis
|
April 9, 2013
Optimising monitoring in the management of Crohn's disease: a physician's perspective
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, et al.
Gastroenterology
|
May 27, 2014
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed
Bruce E Sands, Brian G Feagan, Paul Rutgeerts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
Erwin Dreesen, Filip Baert, David Laharie, et al.
Frontiers in Immunology
|
January 8, 2024
Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients
Ishtu Hageman, Femke Mol, Sadaf Atiqi, et al.
Journal of Crohn'S & Colitis
|
November 10, 2021
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials
Ahmed Almradi, Rocio Sedano, Malcolm Hogan, et al.
The American Journal of Gastroenterology
|
December 18, 2008
Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis
Antoine Cortot, Denis Maetz, Eric Degoutte, et al.
The New England Journal of Medicine
|
June 28, 2023
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Geert D'Haens, Marla Dubinsky, Taku Kobayashi, et al.
Journal of Crohn'S & Colitis
|
April 25, 2015
Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative
Silvio Danese, Gionata Fiorino, Jean-Yves Mary, et al.
Page
of 27
Search research articles
Search
Showing results (151-160 of 269) with videos related to
Sort By:
Page
of 27
Gut
|
February 20, 2016
The safety of vedolizumab for ulcerative colitis and Crohn's disease
Jean-Frédéric Colombel, Bruce E Sands, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
October 3, 2015
Fc Receptor-mediated Effector Function Contributes to the Therapeutic Response of Anti-TNF Monoclonal Antibodies in a Mouse Model of Inflammatory Bowel Disease
Bradford L McRae, Alon D Levin, Manon E Wildenberg, et al.
Journal of Crohn'S & Colitis
|
April 9, 2013
Optimising monitoring in the management of Crohn's disease: a physician's perspective
Pavol Papay, Ana Ignjatovic, Konstantinos Karmiris, et al.
Gastroenterology
|
May 27, 2014
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed
Bruce E Sands, Brian G Feagan, Paul Rutgeerts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 26, 2019
Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
Erwin Dreesen, Filip Baert, David Laharie, et al.
Frontiers in Immunology
|
January 8, 2024
Novel DNA methylome biomarkers associated with adalimumab response in rheumatoid arthritis patients
Ishtu Hageman, Femke Mol, Sadaf Atiqi, et al.
Journal of Crohn'S & Colitis
|
November 10, 2021
Clinical, Endoscopic, and Safety Placebo Rates in Induction and Maintenance Trials of Crohn's Disease: Meta-Analysis of Randomised Controlled Trials
Ahmed Almradi, Rocio Sedano, Malcolm Hogan, et al.
The American Journal of Gastroenterology
|
December 18, 2008
Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis
Antoine Cortot, Denis Maetz, Eric Degoutte, et al.
The New England Journal of Medicine
|
June 28, 2023
Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Geert D'Haens, Marla Dubinsky, Taku Kobayashi, et al.
Journal of Crohn'S & Colitis
|
April 25, 2015
Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative
Silvio Danese, Gionata Fiorino, Jean-Yves Mary, et al.
Page
of 27